Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 11;66(4):e70036.
doi: 10.1002/jmd2.70036. eCollection 2025 Jul.

Mitochondrial DNA Pathogenic Variant Prevalence in Primary Mitochondrial Disease Patients With African (L) Mitochondrial Genome Haplogroups

Affiliations

Mitochondrial DNA Pathogenic Variant Prevalence in Primary Mitochondrial Disease Patients With African (L) Mitochondrial Genome Haplogroups

Surita Meldau et al. JIMD Rep. .

Abstract

Primary mitochondrial diseases (PMD) are caused by pathogenic variants in over 350 genes, 37 of which are located in mitochondrial DNA (mtDNA). While more than 100 mtDNA variants have confirmed disease associations, there are few reports of mtDNA-related PMD in patients with African heritage, even in well-studied populations. We investigated the frequency of pathogenic mtDNA variants in African L-haplogroups in patients with confirmed PMD from two diagnostic cohorts. Data from genetically confirmed mtDNA-related cases were extracted from existing databases at the National Health Laboratory Service Inherited Metabolic Disease Laboratory in South Africa (SA), and the Children's Hospital of Philadelphia (CHOP) Mitochondrial Medicine Frontier Program (USA). Mitochondrial genome haplogroup context was recorded from existing sequence report data. Stored DNA from the remaining cases was sequenced for mitochondrial genome haplogroup determination. Haplogroup context was obtained for 82 SA and 165 CHOP PMD cases. Sixty-two (47 SA; 15 USA) PMD cases from at least 50 maternal lineages were found to carry L Haplogroups. Unique L sub-haplogroups were identified in 11 (9 SA, 2 USA) families with the m.3243A>G MELAS variant, 6 SA families with the m.11778G>A LHON variant, and 20 (15 SA, 5 USA) cases with single large-scale mtDNA deletions (4 of whom had the 4977 bp common deletion). Several additional well-documented mtDNA pathogenic variants were identified in L-haplogroup context. PMD patient clinical features correlated closely with those described in other haplogroup cohorts. This study demonstrates that common pathogenic mtDNA variants occur in the context of multiple African mtDNA lineages. Disproportionately low diagnostic rates highlight ongoing diagnostic inequalities affecting those on the African continent and African patients globally.

Keywords: African American; South Africa; haplogroup L; haplogroup context; primary mitochondrial disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Rahman J. and Rahman S., “Mitochondrial Medicine in the Omics Era,” Lancet 391, no. 10139 (2018): 2560–2574, 10.1016/s0140-6736(18)30727-x. - DOI - PubMed
    1. Gorman G. S., Schaefer A. M., Ng Y., et al., “Prevalence of Nuclear and Mitochondrial DNA Mutations Related to Adult Mitochondrial Disease,” Annals of Neurology 77, no. 5 (2015): 753–759, 10.1002/ana.24362. - DOI - PMC - PubMed
    1. Falk M. J., ed., Mitochondrial Disease Genes Compendium: From Genes to Clinical Manifestations (Academic Press, 2020).
    1. Meldau S., De Lacy R. J., Riordan G. T. M., et al., “Identification of a Single MPV17 Nonsense‐Associated Altered Splice Variant in 24 South African Infants With Mitochondrial Neurohepatopathy,” Clinical Genetics 93, no. 5 (2018): 1093–1096, 10.1111/cge.13208. - DOI - PubMed
    1. Meldau S., Fratter C., Bhengu L. N., et al., “Pitfalls of Relying on Genetic Testing Only to Diagnose Inherited Metabolic Disorders in Non‐Western Populations ‐ 5 Cases of Pyruvate Dehydrogenase Deficiency From South Africa,” Molecular Genetics and Metabolism Reports 24, no. 100629 (2020): 1–3, 10.1016/j.ymgmr.2020.100629. - DOI - PMC - PubMed

LinkOut - more resources